logo
The demand for end-of-life doulas is rising. Here's how they address the physical and emotional needs of those nearing death.

The demand for end-of-life doulas is rising. Here's how they address the physical and emotional needs of those nearing death.

Yahoo06-03-2025

For 24 years, Natalie Ann Evans has worked as a birth doula, providing comfort and support to parents ushering new life into the world. But after caring for her mother in hospice in 2014, another facet of her career opened up.
"I realized how many similarities there were between end-of-life and [birth] doula work. So after [my mother] passed, I started supporting friends and family," Evans told Stacker.
A decade later, Evans decided to pursue end-of-life care and enrolled in a three-month end-of-life doula training program at the University of Vermont. Similar to a birth doula, an EOLD is a nonmedical professional who assists patients and families with the logistical, emotional, psychosocial, and spiritual aspects of dying. Death doulas, as they are sometimes called, are "companions to walk people through the process of dying," said Evans, adding that they give patients the "heart and hands, but also information that they need."
While there's currently no governing organization regulating end-of-life certifications, many doulas choose to get certified. In 2023, the International End-of-Life Doula Association boasted a membership of 1,500, compared to just 300 a few years prior.
The growing interest in and demand for trained individuals to help people transition at the end of life is partly due to what Evans considers an "opening up to accept and talk about what it means to die."
"You can have agency here," she told Stacker. "There's been a cultural shift of people being curious and wanting to know more."
And it's a shift decades in the making.
Many Americans grew up under the false assumption that talking about death was morbid, taboo, and simply inappropriate. However, since the 1960s, American culture has evolved in its approach to and acceptance of mortality, helping to normalize public discussion about death and dying. This is largely attributed to the introduction of hospice care to the United States in the 1970s. Hospice caregivers, like nurses, doctors, and social workers, support end-of-life care, focusing primarily on meeting medical needs and pain management. What began as a volunteer organization in the 1970s has evolved into a federally funded program integral to U.S. medical care.
The movement toward greater transparency around death and dying saw a marked shift in 2011 with several major initiatives. The late John Underwood created Death Cafe, a concept where people meet up in person or virtually to talk about death and grief to help reduce the stigma around these difficult conversations. That same year, end-of-life doulas, also known as death midwives, grew in popularity, and Washington state became the first state to legalize natural organic reduction burials.
This coincided with a budding community that grew into the death-positive movement, now an international phenomenon. It spawned, in part, from mortician Caitlin Doughty's nonprofit initiative, The Order of the Good Death, which aims to help change perceptions of funeral professionals, death, and dying—which was largely accomplished through her Ask a Mortician web series.
This trend has been most recently seen on DeathTok, where a group of real-life hospice workers, morticians, and death workers sing, dance, and improvise about their experiences on TikTok.
Talking candidly about a "good death"—one that is peaceful, meaningful, and in alignment with what the dying person wants and needs—has become more common for several reasons. During the COVID-19 pandemic, mortality was top of mind, and talking about death and dying was normalized. In the process, awareness grew about the gap in addressing the needs of the dying in an increasingly secular society.
Moreover, baby boomers—expected to comprise 22% of the U.S. population by 2040—are aging. By 2030, all boomers will be at least 65 or older; by 2040, about 78.3 million Americans will fall within that age bracket. That means more older adults will need care, and with grown children living further apart from their parents, some will turn to resources outside of the family unit for end-of-life care.
Hospice Care Ratings used KFF and National Hospice and Palliative Care Organization data to highlight hospice use and explain the important role EOLDs can play in helping people die more peacefully and with dignity.
While EOLDs are still not mainstream, hospice care has evolved in the past two decades. The number of Medicaid beneficiaries who used hospice services rose by 30% between 2013 and 2021, according to KFF data. In 2021, 1.7 million Americans accessed hospice care from a pool of 2.6 million beneficiaries who died that year, meaning nearly 66% of patients chose to use hospice services.
Hospice services are palliative, meaning they focus on providing comfort and maintaining a patient's quality of life, not on curing a disease. Patients with a terminal prognosis (a life expectancy of six months or less) are eligible for Medicare hospice coverage, and some enter hospice in the very last weeks of life. The most common diagnoses of hospice patients are neurological diseases, such as Alzheimer's, along with cancer, chronic obstructive pulmonary disease, and heart failure.
Medicare currently offers plans at varying care levels, from inpatient services to routine visits and continuous care, the latter two of which occur in the patient's home. Coverage at all levels includes symptom and pain management, medical supplies, and emotional support.
Visits from a hospice nurse can entail administering medications and monitoring a patient's physical well-being. Sometimes, hospice care includes social workers, chaplain services, and other community resources. They supplement, but do not replace, the role of a primary family caregiver. Even with a hospice team in place, many family caregivers lack the flexibility or experience required to care for a dying loved one.
Many people need more consistent support between visits from hospice aides or even a knowledgeable presence or hand to hold—and that's where EOLDs like Evans come in. Death doulas often provide a bridge between hospice staff and families, helping to facilitate care.
"I will typically do a four- to six- or eight- to 10-hour shift, and I might be reading books and listening to music. I am a long, steady presence, which a hospice nurse can't do," Evans told Stacker.
As awareness grows about the needs of people nearing death, EOLDs are increasingly becoming an integral part of end-of-life services. They help with the emotional and logistical aspects of dying while hospice attends to medical needs. Just as it takes a village to raise a child, it takes one to help someone die ethically and peacefully in the manner that they want.
Evans described her job as having a holistic and practical side, but both involve figuring out what is good for people who are dying, not what they "should" be doing. When she meets with a new patient, she has a checklist: Do you have a will? An ethical will? A legacy project you want to undertake? Who can water your plants? These are the things that often fall through the cracks for families at a stressful time, even if they have the benefit of Medicare-covered hospice care.
Death doulas can also help set up essential documents like health care proxies and do-not-resuscitate orders. They also help facilitate difficult conversations, plan funeral arrangements, and provide support for grieving family members in the weeks and months after their loved one's passing. With EOLDs and hospice staff working in tandem, patients receive a more holistic approach to end-of-life care. This approach means thinking about every step of the process, from illness to health care choice and from how and where you die to how you are buried.
In 2022, nearly half of Medicare patients were enrolled in hospice at the time of their death, though figures vary from state to state. The increase in the use of hospice care services by older adults is a nationwide phenomenon, though usage varies widely.
Utah, Florida, and Rhode Island ranked first, second, and third, respectively, in the percentage of Medicaid beneficiaries who use hospice care benefits, which ranged between 55% and 60%. Meanwhile, New York had the lowest utilization rate at 25%, followed by Washington D.C., Arkansas, and North Dakota, with 40% or less of Medicare populations using their hospice benefits. This illustrates how disparate levels of care across the nation can lead to vastly different caretaking and end-of-life experiences.
The average length of stay in hospice is 92 days, and half of patients were enrolled for 17 days or less, but Medicare hospice coverage varies from state to state. For example, Alabama currently has the highest number of average hospice days covered by Medicaid at 91.3 days, while Wyoming ranks last with only 47.65, according to 2021 KFF data.
For those who don't qualify for Medicare and Medicaid coverage, private insurance, employment-based plans, and some long-term care insurance plans offer hospice coverage, typically with similar eligibility requirements as federal programs. However, about 8% of the U.S. population is uninsured, according to 2024 Census Bureau data.
This includes Americans stuck in the economic middle who do not qualify for federal assistance but don't have private insurance or the funds to cover additional medical expenses.
Nonprofit and specialty groups are filling some of the gaps and making coverage possible for more people. All enrolled veterans are eligible for hospice care through the Veterans Association; those with terminal cancer may qualify for additional services. Similarly, a plethora of free social services and resources are available for older adults through religious-affiliated organizations like The National Institute for Jewish Hospice and the Muslim Spiritual Care and Hospice Network, as well as many local Christian organizations.
Currently, Medicare does not cover EOLDs, but Evans believes the landscape may be shifting. She hopes that in a year or two, it might be standard practice to have death doulas covered by Medicare and Medicaid. Birth doulas, which weren't covered by insurance until recently, are now classified as a preventative service by Medicaid and eligible for reimbursement in a handful of states, including California, Oregon, Michigan, and New Jersey.
If the path of birth doulas sets a precedent, increasing the understanding of birth as a highly specific, holistic experience paved the way. As the population ages, hospice care use continues to rise. As more families grapple with loss, awareness and understanding about the emotional and spiritual needs of people who are dying and their loved ones will likely also expand—something Evans has long hoped for.
"My job is to listen to what people want," Evans said. "Dying is a personal experience."
Story editing by Alizah Salario. Copy editing by Janina Lawrence. Photo selection by Ania Antecka.
This story originally appeared on Hospice Care Ratings and was produced and distributed in partnership with Stacker Studio.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chrononutrition guide: Is when you eat as important as what you eat?
Chrononutrition guide: Is when you eat as important as what you eat?

Yahoo

timean hour ago

  • Yahoo

Chrononutrition guide: Is when you eat as important as what you eat?

Americans have long heard about the health benefits of adhering to diets rich in fresh produce and whole grains and low in red meat and processed sugars. But they may not be aware of how meal timing can affect their health. A recent publication from the UF/IFAS department of food science and human nutrition describes chrononutrition, an emerging field of study that connects eating with circadian rhythm, the body's 24-hour internal clock. How someone schedules meals throughout the day can impact their weight and body mass index (BMI) as well as increase their odds of developing cardiometabolic diseases, including type 2 diabetes, according to the authors of the publication, an Ask IFAS guide. 'Healthy eating is not only what you eat but also how much you eat and when,' said doctoral candidate Kaylyn Koons, the publication's lead author. Franz Halberg, a Romanian-born physician, introduced the idea of chrononutrition in 1967. The concept is based on the premise that the sleep and wake cycle regulates bodily functions, including metabolism and digestion, so the timing, frequency and consistency of food intake affects health. There is a broad range of eating behaviors that influence chrononutrition, according to the UF/IFAS guide. One of the key behaviors relates to the 'eating window,' the time frame between the first meal of the day and the last. Optimizing that window — typically between 8 and 12 hours — could realign food intake with the circadian clock. In fact, a systematic review of studies on time-restricted eating with an eating window of 12 hours or less found an average weight loss of 3%, along with reductions in fasting blood glucose, systolic blood pressure, waist circumference, and LDL cholesterol levels. Many eating behaviors related to poor chrononutrition center around evening food consumption. Eating at or after 8 p.m. is associated with weight gain and metabolic disorders, for example. Potential reasons include the prevalence of poorer food choices at night and late eaters' propensity to stay up late, which can negatively impact sleep. Evening latency, the amount of time that lapses between eating the last meal of the day and sleeping, can also play a part, according to the guide. It describes a 2023 study of Malaysian college students which found that those who didn't observe a delay between eating dinner and sleeping were more likely to be underweight. 'This finding may seem counterintuitive because you might expect this behavior would reduce energy expenditure and promote weight gain rather than weight loss,' Koons said. 'But it could be associated with other adverse chrononutrition habits such as skipping meals or irregular meal timing, which lead to an overall reduced calorie intake.' Koons recommends anyone desiring to improve their chrononutrition examine their eating behaviors and identify chrononutrition-related behaviors that may be negatively affecting their health. Then they can set attainable goals to reduce the frequency of those behaviors. Patience is key, however, she said. 'Eating habits tend to be ingrained in routine and become habitual,' Koons said. 'It's important to remember that behavior change is difficult, and it takes time.' This article originally appeared on Tallahassee Democrat: When you eat may be as important as what you eat

Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk

Time​ Magazine

time2 hours ago

  • Time​ Magazine

Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk

When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans.

Widely-used drug can seriously increase women's odds of living to age 90
Widely-used drug can seriously increase women's odds of living to age 90

New York Post

time2 hours ago

  • New York Post

Widely-used drug can seriously increase women's odds of living to age 90

Time to re-up that AARP subscription. A popular prescription drug already in millions of medicine cabinets could be the key to unlocking a longer life for women. New research published in the Journal of Gerontology: Medical Sciences found that those taking this widely-used diabetes drug had a great shot at making it to the big 9-0. JackF – No, it's not Ozempic — it's called metformin, and almost 20 million Americans are estimated to be taking it to help manage their Type 2 diabetes. Like other diabetes drugs, this decades-old, dirt-cheap medication works by decreasing the amount of glucose the body absorbs from food and improves its response to insulin. Also used to treat Polycystic Ovary Syndrome (PCOS), metformin has often been hailed as a 'wonder drug' due to its other health benefits, including improving fertility in women, aiding in weight management and even reducing the risks of heart disease and certain cancers. This new study set its sights on promising research indicating it may also have anti-aging effects. Researchers analyzed the data of 438 postmenopausal women — half of whom were on metformin, the other half of whom took another diabetes drug called sulfonylurea. Like other diabetes drugs, metformin works by decreasing the amount of glucose the body absorbs from food and improves its response to insulin. Halfpoint – They found that those in the metformin group had a 30% higher chance of making it to 90 when compared to the sulfonylurea group. The study has a few limitations, the most notable of which is that it had no control group — meaning none of the participants weren't on diabetes medication — as well as a relatively small sample size. However, one of its strengths was a follow-up period of 14-15 years, which is much longer than the average randomized controlled trial. All told, the new study adds to an increasing body of research on the geroscience hypothesis, which posits that 'biological aging is malleable and that slowing biological aging may delay or prevent the onset of multiple age-related diseases and disability,' the researchers wrote. The new study backs up previous research published last year which showed that metformin can slow aging and also prevent disease in healthy older adults. 'I don't know if metformin increases lifespan in people, but the evidence that exists suggests that it very well might,' Steven Austad, a senior scientific adviser at the American Federation for Aging Research who studies the biology of agin, told NPR. While scientists figure out how to biohack our systems, this little pill may just propel you into your golden years.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store